ClinConnect ClinConnect Logo
Search / Trial NCT07044752

Step 1: Be Aware, Anxiety Prevention Intervention

Launched by YALE UNIVERSITY · Jun 25, 2025

Trial Information

Current as of October 02, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study is testing a 5-week, community-based program designed to help prevent anxiety in urban youth of color in Paterson, New Jersey. It’s not a drug or medical device. The program is run in schools and through community engagement, with sessions led by trained facilitators who include someone from the local community to keep it culturally relevant. All participants would receive the intervention—there is no comparison group in this single-group design—and researchers will measure anxiety symptoms at baseline, after the five sessions, and about three months later using a short questionnaire called the GAD-7.

About who can join: the study plans to enroll about 50 youths aged 13 to 21 who live in Paterson and can read and speak English, and who give their consent to participate. Key exclusions are not being able to read/write English, not residing in Paterson, or not providing consent. Recruitment will involve collaboration with a local high school. At this stage, the trial is actively enrolling by invitation, with results not yet available. The study is led by Yale University.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • able to speak and read in English
  • reside in Paterson
  • Exclusion Criteria:
  • English is not first language and cannot read or write English
  • Does not have residence in Paterson
  • Has not provided consent to participate in study

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

Paterson, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

Ijeoma Opara, PhD

Principal Investigator

Yale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported